|
Market Closed -
Nasdaq
00:00:01 21/11/2026 +03
|
5-day change | 1st Jan Change | ||
| 0.9001 USD | +11.12% |
|
+9.77% | +29.94% |
| 11-06 | Elutia Inc., Q3 2026 Earnings Call, Nov 05, 2026 | |
| 11-06 | Elutia Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026 | CI |
| Market Cap | 39.96M 36.4M 33.54M 30.51M 57.23M 3.7B 60.15M 408M 162M 2.02B 150M 147M 6.34B | P/E 2026 * |
-1.36x | P/E 2027 * | -1.43x |
|---|---|---|---|---|---|
| Enterprise Value | 39.96M 36.4M 33.54M 30.51M 57.23M 3.7B 60.15M 408M 162M 2.02B 150M 147M 6.34B | EV / Sales 2026 * |
5.33x | EV / Sales 2027 * | 9.29x |
| Free-Float |
85.22% | Yield 2026 * |
-
| Yield 2027 * | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ELUT | Delayed | |
| ELUT | Real-time |
Last Transcript: Elutia Inc.
| 1 day | +11.12% | ||
| 1 week | +9.77% | ||
| Current month | +7.53% | ||
| 1 month | +9.39% | ||
| 3 months | -5.34% | ||
| 6 months | -24.99% | ||
| Current year | +29.94% |
| 1 week | 0.79 | 0.92 | |
| 1 month | 0.7 | 0.96 | |
| Current year | 0.6 | 1.38 | |
| 1 year | 0.5 | 1.38 | |
| 3 years | 0.5 | 5.24 | |
| 5 years | 0.5 | 9.01 | |
| 10 years | 0.5 | 18.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Charles Mills
CEO | Chief Executive Officer | 54 | 21/06/2022 |
| Chief Operating Officer | 52 | - | |
Matthew Ferguson
DFI | Director of Finance/CFO | 58 | 28/09/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Kevin Rakin
CHM | Chairman | 65 | 01/11/2015 |
Charles Mills
BRD | Director/Board Member | 54 | 01/11/2015 |
Brigid Makes
BRD | Director/Board Member | 70 | 01/09/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/10/26 A | Exercice | Founder | 63,884 | 0.1445% | ||
| 9/10/26 A | Exercice | Founder | 29,269 | 0.0662% | ||
| 9/10/26 A | Exercice | Chief Financial Officer | 29,486 | 0.0667% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +11.12% | +9.77% | +52.53% | -44.78% | 39.96M | ||
| -0.30% | -6.68% | +27.12% | +127.32% | 1,200B | ||
| +1.25% | -5.35% | +32.65% | +78.98% | 651B | ||
| +0.94% | -2.99% | +21.13% | +106.30% | 506B | ||
| -0.60% | -1.95% | +25.73% | +67.00% | 377B | ||
| +0.69% | -9.50% | +36.78% | +30.83% | 330B | ||
| +0.41% | -4.70% | +24.18% | +50.18% | 288B | ||
| +0.81% | -4.08% | -2.95% | +31.59% | 272B | ||
| -0.15% | -6.45% | +29.06% | +65.76% | 236B | ||
| -0.06% | -0.98% | +31.42% | +122.83% | 206B | ||
| Average | +1.41% | -3.30% | +27.77% | +63.60% | 407B | |
| Weighted average by Cap. | +0.30% | -5.19% | +26.02% | +87.87% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 7.5M 6.83M 6.29M 5.73M 10.74M 695M 11.29M 76.61M 30.45M 379M 28.14M 27.55M 1.19B | 4.3M 3.92M 3.61M 3.28M 6.16M 398M 6.47M 43.92M 17.46M 217M 16.13M 15.79M 683M |
| Net income | -27.3M -24.86M -22.91M -20.84M -39.1M -2.53B -41.09M -279M -111M -1.38B -102M -100M -4.33B | -23.6M -21.49M -19.81M -18.02M -33.8M -2.19B -35.52M -241M -95.81M -1.19B -88.55M -86.68M -3.75B |
| Net Debt | - | - |
Employees
26
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/11/26 | $0.9001 | +11.12% | 83,880 |
| 19/11/26 | $0.8100 | -2.41% | 20,732 |
| 18/11/26 | $0.8300 | -2.80% | 14,519 |
| 17/11/26 | $0.8539 | +3.77% | 49,962 |
| 16/11/26 | $0.8229 | +0.35% | 53,867 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.9001USD
Average target price
5.000USD
Spread / Average Target
+455.49%
- Stock Market
- Stocks
- ELUT Stock
Select your edition
All financial news and data tailored to specific country editions
















